Skip to main content
Erschienen in: Acta Neuropathologica 3/2011

01.09.2011 | Original Paper

Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment

verfasst von: Grazia Devigili, Nurcan Üçeyler, Marcus Beck, Karlheinz Reiners, Guido Stoll, Klaus V. Toyka, Claudia Sommer

Erschienen in: Acta Neuropathologica | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with variable involvement of other systems. A pathogenetic role of immune-mediated mechanisms has been suggested. We retrospectively analyzed sural nerve pathology and the clinical course in 18 patients with ALS. These patients had undergone sural nerve biopsy because of clinical or neurophysiological signs indicating sensory involvement (ALS+). Eleven of the 18 ALS+ patients had inflammatory cell infiltrates (ALSvasc) resembling infiltrates seen in patients with vasculitic neuropathy. Data were compared with the 7 patients without vasculitic infiltrates (ALSnonvasc) and with those of 16 patients with isolated peripheral nerve vasculitis (NPvasc). Biopsy specimens were processed with standard histological stains and with immunohistochemistry for a panel of inflammatory markers, with the hypothesis that the composition of infiltrates should differ between ALSvasc and NPvasc. Immunoreactive cells were quantified in a blinded manner. Unlike patients with NPvasc, those with ALSvasc had only minor neurophysiological abnormalities in the sural nerve and, except for the infiltrates, almost normal nerve morphology on semithin sections. The difference in epineurial T cell count was significant between ALSvasc and ALSnonvasc (p = 0.031). Surprisingly, the cellular composition of epineurial infiltrates in sural nerve biopsies was indistinguishable between ALSvasc and NPvasc despite a significant difference in fiber pathology (p < 0.0001). Standard immunosuppressive treatment did not prevent clinical progression of the motor neuron disease in any of the patients with ALSvasc. ALSvasc appears as a neuropathological subtype in ALS+ suggesting immune-mediated disease components but without response to standard immunosuppressive treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Almer G, Vukosavic S, Romero N et al (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72:2415–2425PubMedCrossRef Almer G, Vukosavic S, Romero N et al (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72:2415–2425PubMedCrossRef
2.
Zurück zum Zitat Amoiridis G, Tsimoulis D, Ameridou I (2008) Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 71:779PubMedCrossRef Amoiridis G, Tsimoulis D, Ameridou I (2008) Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 71:779PubMedCrossRef
3.
Zurück zum Zitat Appel SH, Smith RG, Alexianu M et al (1995) Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clin Neurosci 3:368–374PubMed Appel SH, Smith RG, Alexianu M et al (1995) Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clin Neurosci 3:368–374PubMed
4.
Zurück zum Zitat Banerjee R, Mosley RL, Reynolds AD et al (2008) Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One 3:e2740PubMedCrossRef Banerjee R, Mosley RL, Reynolds AD et al (2008) Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One 3:e2740PubMedCrossRef
5.
Zurück zum Zitat Berghoff M, Samsam M, Muller M et al (2005) Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene. Mol Cell Neurosci 28:118–127PubMedCrossRef Berghoff M, Samsam M, Muller M et al (2005) Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene. Mol Cell Neurosci 28:118–127PubMedCrossRef
6.
Zurück zum Zitat Bradley WG, Good P, Rasool CG et al (1983) Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol 14:267–277PubMedCrossRef Bradley WG, Good P, Rasool CG et al (1983) Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol 14:267–277PubMedCrossRef
7.
Zurück zum Zitat Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299PubMedCrossRef Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299PubMedCrossRef
8.
Zurück zum Zitat Collins MP, Dyck PJ, Gronseth GS et al (2010) Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 15:176–184PubMedCrossRef Collins MP, Dyck PJ, Gronseth GS et al (2010) Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 15:176–184PubMedCrossRef
9.
Zurück zum Zitat Collins MP, Mendell JR, Periquet MI et al (2000) Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 55:636–643PubMed Collins MP, Mendell JR, Periquet MI et al (2000) Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 55:636–643PubMed
10.
Zurück zum Zitat Davies L, Spies JM, Pollard JD et al (1996) Vasculitis confined to peripheral nerves. Brain 119(Pt 5):1441–1448PubMedCrossRef Davies L, Spies JM, Pollard JD et al (1996) Vasculitis confined to peripheral nerves. Brain 119(Pt 5):1441–1448PubMedCrossRef
11.
Zurück zum Zitat Demestre M, Orth M, Wells GM et al (2005) Characterization of matrix metalloproteinases in denervated muscle. Neuropathol Appl Neurobiol 31:545–555PubMedCrossRef Demestre M, Orth M, Wells GM et al (2005) Characterization of matrix metalloproteinases in denervated muscle. Neuropathol Appl Neurobiol 31:545–555PubMedCrossRef
12.
Zurück zum Zitat Desurkar A, Lin JP, Mills K et al (2009) Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children. Neuropediatrics 40:85–88PubMedCrossRef Desurkar A, Lin JP, Mills K et al (2009) Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children. Neuropediatrics 40:85–88PubMedCrossRef
13.
Zurück zum Zitat Drachman DB, Chaudhry V, Cornblath D et al (1994) Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol 35:142–150PubMedCrossRef Drachman DB, Chaudhry V, Cornblath D et al (1994) Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol 35:142–150PubMedCrossRef
14.
Zurück zum Zitat Dyck PJ, Benstead TJ, Conn DL et al (1987) Nonsystemic vasculitic neuropathy. Brain 110(Pt 4):843–853PubMedCrossRef Dyck PJ, Benstead TJ, Conn DL et al (1987) Nonsystemic vasculitic neuropathy. Brain 110(Pt 4):843–853PubMedCrossRef
15.
Zurück zum Zitat Echaniz-Laguna A, Degos B, Mohr M et al (2006) A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP. Muscle Nerve 33:356–362PubMedCrossRef Echaniz-Laguna A, Degos B, Mohr M et al (2006) A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP. Muscle Nerve 33:356–362PubMedCrossRef
16.
Zurück zum Zitat Edgar JM, McCulloch MC, Montague P et al (2010) Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med 2:42–50PubMedCrossRef Edgar JM, McCulloch MC, Montague P et al (2010) Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med 2:42–50PubMedCrossRef
17.
Zurück zum Zitat Elliott JL (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95:172–178PubMedCrossRef Elliott JL (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95:172–178PubMedCrossRef
18.
Zurück zum Zitat Fang L, Huber-Abel F, Teuchert M et al (2009) Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 285:62–66PubMedCrossRef Fang L, Huber-Abel F, Teuchert M et al (2009) Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 285:62–66PubMedCrossRef
19.
20.
Zurück zum Zitat Ghezzi P, Bernardini R, Giuffrida R et al (1998) Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. Eur Cytokine Netw 9:139–144PubMed Ghezzi P, Bernardini R, Giuffrida R et al (1998) Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. Eur Cytokine Netw 9:139–144PubMed
21.
Zurück zum Zitat Ginsberg L, Malik O, Kenton AR et al (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202PubMedCrossRef Ginsberg L, Malik O, Kenton AR et al (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202PubMedCrossRef
22.
Zurück zum Zitat Hamada M, Hanajima R, Terao Y et al (2007) Median nerve somatosensory evoked potentials and their high-frequency oscillations in amyotrophic lateral sclerosis. Clin Neurophysiol 118:877–886PubMedCrossRef Hamada M, Hanajima R, Terao Y et al (2007) Median nerve somatosensory evoked potentials and their high-frequency oscillations in amyotrophic lateral sclerosis. Clin Neurophysiol 118:877–886PubMedCrossRef
23.
Zurück zum Zitat Hammad M, Silva A, Glass J et al (2007) Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 69:2236–2242PubMedCrossRef Hammad M, Silva A, Glass J et al (2007) Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 69:2236–2242PubMedCrossRef
24.
Zurück zum Zitat Hilz MJ, Axelrod FB, Hermann K et al (1998) Normative values of vibratory perception in 530 children, juveniles and adults aged 3–79 years. J Neurol Sci 159:219–225PubMedCrossRef Hilz MJ, Axelrod FB, Hermann K et al (1998) Normative values of vibratory perception in 530 children, juveniles and adults aged 3–79 years. J Neurol Sci 159:219–225PubMedCrossRef
25.
26.
Zurück zum Zitat Ip CW, Kroner A, Kohl B et al (2009) Tacrolimus (FK506) causes disease aggravation in models for inherited peripheral myelinopathies. Neurobiol Dis 33:207–212PubMedCrossRef Ip CW, Kroner A, Kohl B et al (2009) Tacrolimus (FK506) causes disease aggravation in models for inherited peripheral myelinopathies. Neurobiol Dis 33:207–212PubMedCrossRef
27.
Zurück zum Zitat Isaacs JD, Dean AF, Shaw CE et al (2007) Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry 78:750–753PubMedCrossRef Isaacs JD, Dean AF, Shaw CE et al (2007) Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry 78:750–753PubMedCrossRef
28.
Zurück zum Zitat Kawamura Y, Dyck PJ, Shimono M et al (1981) Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 40:667–675PubMedCrossRef Kawamura Y, Dyck PJ, Shimono M et al (1981) Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 40:667–675PubMedCrossRef
29.
Zurück zum Zitat Kerkhoff H, Jennekens FG, Troost D et al (1991) Nerve growth factor receptor immunostaining in the spinal cord and peripheral nerves in amyotrophic lateral sclerosis. Acta Neuropathol 81:649–656PubMedCrossRef Kerkhoff H, Jennekens FG, Troost D et al (1991) Nerve growth factor receptor immunostaining in the spinal cord and peripheral nerves in amyotrophic lateral sclerosis. Acta Neuropathol 81:649–656PubMedCrossRef
30.
Zurück zum Zitat Kerkhoff H, Troost D, Louwerse ES et al (1993) Inflammatory cells in the peripheral nervous system in motor neuron disease. Acta Neuropathol 85:560–565PubMedCrossRef Kerkhoff H, Troost D, Louwerse ES et al (1993) Inflammatory cells in the peripheral nervous system in motor neuron disease. Acta Neuropathol 85:560–565PubMedCrossRef
31.
Zurück zum Zitat Kimura J (2001) Electrodiagnosis in diseases of nerve and muscle: principles and practice, 3rd edn. Oxford University Press, New York Kimura J (2001) Electrodiagnosis in diseases of nerve and muscle: principles and practice, 3rd edn. Oxford University Press, New York
32.
Zurück zum Zitat Kobsar I, Berghoff M, Samsam M et al (2003) Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 126:804–813PubMedCrossRef Kobsar I, Berghoff M, Samsam M et al (2003) Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 126:804–813PubMedCrossRef
33.
Zurück zum Zitat Li M, Ona VO, Guegan C et al (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288:335–339PubMedCrossRef Li M, Ona VO, Guegan C et al (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288:335–339PubMedCrossRef
34.
Zurück zum Zitat Lincecum JM, Vieira FG, Wang MZ et al (2010) From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet 42:392–399PubMedCrossRef Lincecum JM, Vieira FG, Wang MZ et al (2010) From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet 42:392–399PubMedCrossRef
35.
Zurück zum Zitat Lorenzl S, Narr S, Angele B et al (2006) The matrix metalloproteinases inhibitor Ro 28–2653 (correction of Ro 26–2853) extends survival in transgenic ALS mice. Exp Neurol 200:166–171PubMedCrossRef Lorenzl S, Narr S, Angele B et al (2006) The matrix metalloproteinases inhibitor Ro 28–2653 (correction of Ro 26–2853) extends survival in transgenic ALS mice. Exp Neurol 200:166–171PubMedCrossRef
36.
Zurück zum Zitat Mantovani S, Garbelli S, Pasini A et al (2009) Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol 210:73–79PubMedCrossRef Mantovani S, Garbelli S, Pasini A et al (2009) Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol 210:73–79PubMedCrossRef
37.
Zurück zum Zitat Martini R, Toyka KV (2004) Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 3:457–465PubMedCrossRef Martini R, Toyka KV (2004) Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 3:457–465PubMedCrossRef
38.
Zurück zum Zitat Mondelli M, Rossi A, Passero S et al (1993) Involvement of peripheral sensory fibers in amyotrophic lateral sclerosis: electrophysiological study of 64 cases. Muscle Nerve 16:166–172PubMedCrossRef Mondelli M, Rossi A, Passero S et al (1993) Involvement of peripheral sensory fibers in amyotrophic lateral sclerosis: electrophysiological study of 64 cases. Muscle Nerve 16:166–172PubMedCrossRef
39.
Zurück zum Zitat Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M et al (2007) Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 78:746–749PubMedCrossRef Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M et al (2007) Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 78:746–749PubMedCrossRef
40.
Zurück zum Zitat Rajabally YA, Jacob S (2008) Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis. Muscle Nerve 38:855–860PubMedCrossRef Rajabally YA, Jacob S (2008) Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis. Muscle Nerve 38:855–860PubMedCrossRef
41.
Zurück zum Zitat Sakai K, Komai K, Yanase D et al (2005) Plasma VEGF as a marker for the diagnosis and treatment of vasculitic neuropathy. J Neurol Neurosurg Psychiatry 76:296PubMedCrossRef Sakai K, Komai K, Yanase D et al (2005) Plasma VEGF as a marker for the diagnosis and treatment of vasculitic neuropathy. J Neurol Neurosurg Psychiatry 76:296PubMedCrossRef
42.
Zurück zum Zitat Schmidt B, Toyka KV, Kiefer R et al (1996) Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19:474–487PubMedCrossRef Schmidt B, Toyka KV, Kiefer R et al (1996) Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19:474–487PubMedCrossRef
43.
Zurück zum Zitat Shefner JM, Tyler HR, Krarup C (1991) Abnormalities in the sensory action potential in patients with amyotrophic lateral sclerosis. Muscle Nerve 14:1242–1246PubMedCrossRef Shefner JM, Tyler HR, Krarup C (1991) Abnormalities in the sensory action potential in patients with amyotrophic lateral sclerosis. Muscle Nerve 14:1242–1246PubMedCrossRef
44.
Zurück zum Zitat Theys PA, Peeters E, Robberecht W (1999) Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques. J Neurol 246:438–442PubMedCrossRef Theys PA, Peeters E, Robberecht W (1999) Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques. J Neurol 246:438–442PubMedCrossRef
Metadaten
Titel
Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment
verfasst von
Grazia Devigili
Nurcan Üçeyler
Marcus Beck
Karlheinz Reiners
Guido Stoll
Klaus V. Toyka
Claudia Sommer
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 3/2011
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-011-0837-8

Weitere Artikel der Ausgabe 3/2011

Acta Neuropathologica 3/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.